Citations Report

Clinical Practice : Citations & Metrics Report

Articles published in Clinical Practice have been cited by esteemed scholars and scientists all around the world.

Clinical Practice has got h-index 29, which means every article in Clinical Practice has got 29 average citations.

Following are the list of articles that have cited the articles published in Clinical Practice.

  2021 2020 2019 2018 2017 2016

Year wise published articles

51 27 55 66 38 13

Year wise citations received

494 462 352 277 260 226
Journal total citations count 3847
Journal impact factor 5.45
Journal 5 years impact factor 5.66
Journal cite score 6.20
Journal h-index 29
Journal h-index since 2017 21
Journal Impact Factor 2020 formula
IF= Citations(y)/{Publications(y-1)+ Publications(y-2)} Y= Year
Journal 5-year Impact Factor 2020 formula
Citations(2016 + 2017 + 2018 + 2019 + 2020)/
{Published articles(2016 + 2017 + 2018 + 2019 + 2020)}
Journal citescore
Citescorey = Citationsy + Citationsy-1 + Citationsy-2 + Citations y-3 / Published articlesy + Published articlesy-1 + Published articlesy-2 + Published articles y-3
  • Sabzghabaee AM, Eizadi-Mood N, Gheshlaghi F, Adib N and Safaeian L, (2011) Is there a relationship between admission blood glucose level following acute poisoning and clinical outcome. Arch Med Sci, 7(1), pp.81-6. View at Publisher | View at Google Scholar | View at Indexing
  • Kamyab H, Hejrati S, Khanavi M, Malihi F, Mohammadirad A, et al. (2010) Hepatic mechanisms of the Walnut antidiabetic effect in mice. Central European Journal of Biology, 5(3), pp.304-309. View at Publisher | View at Google Scholar | View at Indexing
  • Shadnia S, Rahimi M, Soltaninejad K and Nilli A, (2013) Role of clinical and paraclinical manifestations of methanol poisoning in outcome prediction. Journal of research in medical sciences, 18(10). View at Publisher | View at Google Scholar | View at Indexing
  • Honarmand H, Abdollahi M, Ahmadi A, Javadi MR, Khoshayand MR, et al. (2012) Randomized trial of the effect of intravenous paracetamol on inflammatory biomarkers and outcome in febrile critically ill adults. DARU Journal of Pharmaceutical Sciences, 20(1), p.12. View at Publisher | View at Google Scholar | View at Indexing
  • Hashemi M, Bahari A and Ghavami GBS, (2008) Coenzyme Q10 may be effective in the treatment of non alcoholic fatty liver disease (NAFLD). Journal of Medical Hypotheses and Ideas, 2, pp.9-10. View at Publisher | View at Google Scholar | View at Indexing
  • Rastegarpanah M and Mojtahedzadeh M, (2007) Suppress or not to suppress gastric acid? Intra-gastric pH monitoring Vs. Litmus paper in critically ill patients. Journal of Medical Hypotheses and Ideas, 1, pp.2-3. View at Publisher | View at Google Scholar | View at Indexing
  • Alizadeh N, Khalili H, Mohammadi M, Abdollahi A and Ala S, (2016) Effect of vitamin D on stress‐induced hyperglycaemia and insulin resistance in critically ill patients. International journal of clinical practice, 70(5), pp.396-405. View at Publisher | View at Google Scholar | View at Indexing
  • Jivanji CJ, Asrani VM, Windsor JA and Petrov MS, (2017) March. New-onset diabetes after acute and critical illness: a systematic review. In Mayo Clinic Proceedings. Elsevier. View at Publisher | View at Google Scholar | View at Indexing
  • Thomson ISI, (2012) Mahnaz Khanavi, Marzieh Taheri, Afsaneh Rajabi, Saeed Fallah-Bonekohal, Maryam Baeeri, Azadeh Mohammadirad, Gholamreza Amin and Mohammad Abdollahi. Asian Journal of Animal and Veterinary Advances, 7(11), pp.1166-1174.

    View at Publisher | View at Google Scholar
  • Thomson ISI, (2012) Saeideh Momtaz and Mohammad Abdollahi. Asian Journal of Animal and Veterinary Advances, 7(1), pp.1-19.

    View at Publisher | View at Google Scholar
  • Rastegarpanah M and Mojtahedzadeh M, (2007) Iranian Journal of Medical Hypotheses & Ideas. Irn J Med Hypotheses Ideas, 1, p.2.

    View at Publisher | View at Google Scholar
  • Thomson ISI, (2010) Sarah Mousavi, Mojtaba Mojtahedzadeh and Mohammad Abdollahi. International Journal of Pharmacology, 6(4), pp.326-337.

    View at Publisher | View at Google Scholar
  • Price H, (2012) 1 Best Practice Tariffs for Diabetic Ketoacidosis and Hypoglycaemia. View at Publisher | View at Google Scholar | View at Indexing
  • Abdollahi M, (2008) Alteration of Serum Levels of Interlukin 1 and Tumor Necrosis Factor in Depression Independent of Treatment or Overdose of Tricyclic Antidepressants. J. Med. Sci, 8(3), pp.287-292.

    View at Publisher | View at Google Scholar
  • Thomson ISI, Pooneh Salari and Mohammad Abdollahi (2011) International Journal of Pharmacology, 7(5), pp.552-567.

    View at Publisher | View at Google Scholar
  • Rouini R, Moradi M, Mohammadirad A and Abdollahi M, (2007) Improvement by N-acetylcysteine of acute respiratory distress syndrome through increasing. Human & Experimental Toxicology, 26, pp.697-703. View at Publisher | View at Google Scholar | View at Indexing
  • Foda DS, Farrag EK, Metwally NS, Maghraby AS, Farrag ARH, et al. (2016) Protective and therapeutic impact of taurine on some biochemical, immunological and histological parameters in diabetic rats. Journal of Applied Pharmaceutical Science Vol, 6(10), pp.045-054. View at Publisher | View at Google Scholar | View at Indexing
  • Hashemi M, Bahari A, Bahari G and Ghavami S, (2008) Iranian Journal of Medical Hypotheses and Ideas. Irn J Med Hypotheses Ideas, 2, p.9.

    View at Publisher | View at Google Scholar
  • Baeeri M, Momtaz S, Navaei-Nigjeh M, Niaz K, Rahimifard M, et al. (2017) Molecular evidence on the protective effect of ellagic acid on phosalone-induced senescence in rat embryonic fibroblast cells. Food and Chemical Toxicology, 100, pp.8-23. View at Publisher | View at Google Scholar | View at Indexing
  • Coughlin M, Fanous M and Velanovich V, (2011) Citation of This Article Corresponding Author of This Article Keywords for Related Literature of This Article Article-Type of This Article Open-Access Policy of This Article. World, 3(2), pp.29-30.

    View at Publisher | View at Google Scholar
  • Hasani-Ranjbar S, Nayebi N, Larijani B and Abdollahi M, (2009) Citation of This Article Corresponding Author of This Article Keywords for Related Literature of This Article Article-Type of This Article Open-Access Policy of This Article. World J Gastroenterol, 15(25), pp.3073-3085.

    View at Publisher | View at Google Scholar
  • Abdollahi M, (2012) A comprehensive review of biochemical and molecular evidences from animal and human studies on the role of oxidative stress in aging: an epiphenomenon or the cause. View at Publisher | View at Google Scholar | View at Indexing
  • Khaksar MR, Rahimifard M, Baeeri M, Maqbool F, Navaei-Nigjeh M, et al. (2017) Protective effects of cerium oxide and yttrium oxide nanoparticles on reduction of oxidative stress induced by sub-acute exposure to diazinon in the rat pancreas. Journal of Trace Elements in Medicine and Biology, 41, pp.79-90. View at Publisher | View at Google Scholar | View at Indexing
  • Saadi HS, Baeeri M and Abdollahi M, (2012) MA Rezvanfar, MA Rezvanfar, A Ahmadi 3. Human and Experimental Toxicology, 31(9), pp.887-897. View at Publisher | View at Google Scholar | View at Indexing
  • Rastgarpanah M and Mujtahidzade M, (2007) The decrease or lack of stomach acid reduction? Intragastric pH monitoring probe in comparison with Paper in intensive care patients. Journal of Medical Hypotheses and Ideas, 1, pp.2-3.

    View at Publisher | View at Google Scholar
  • Allemann Y, Fraile B, Lambert M, Barbier M, Ferber P, et al. 2008. Efficacy of the combination of amlodipine and valsartan in patients with hypertension uncontrolled with previous monotherapy: The Exforge in Failure after Single Therapy (EX‐FAST) study. The Journal of Clinical Hypertension, 10(3), pp.185-194. View at Publisher | View at Google Scholar | View at Indexing
  • Destro M, Luckow A, Samson M, Kandra A and Brunel P, 2008. Efficacy and safety of amlodipine/valsartan compared with amlodipine monotherapy in patients with stage 2 hypertension: a randomized, double-blind, multicenter study: the EX-EFFeCTS Study. Journal of the American Society of Hypertension, 2(4), pp.294-302.

    View at Publisher | View at Google Scholar
  • Schrader J, Salvetti A, Calvo C, Akpinar E, Keeling L, et al. 2009. The combination of amlodipine/valsartan 5/160 mg produces less peripheral oedema than amlodipine 10 mg in hypertensive patients not adequately controlled with amlodipine 5 mg. International journal of clinical practice, 63(2), pp.217-225. View at Publisher | View at Google Scholar | View at Indexing
  • Bakris GL, 2008. Combined therapy with a calcium channel blocker and an angiotensin II type 1 receptor blocker. The Journal of Clinical Hypertension, 10(s1), pp.27-32. View at Publisher | View at Google Scholar | View at Indexing
  • Ke Y, Zhu D, Hong H, Zhu J, Wang R, et al. 2010. Efficacy and safety of a single-pill combination of amlodipine/valsartan in Asian hypertensive patients inadequately controlled with amlodipine monotherapy. Current medical research and opinion, 26(7), pp.1705-1713. View at Publisher | View at Google Scholar | View at Indexing
  • Sinkiewicz W, Glazer RD, Kavoliuniene A, Miglinas M, Prak H, et al. 2009. Efficacy and tolerability of amlodipine/valsartan combination therapy in hypertensive patients not adequately controlled on valsartan monotherapy. Current medical research and opinion, 25(2), pp.315-324. View at Publisher | View at Google Scholar | View at Indexing
  • Weir MR, 2008. Risk‐Based Classification of Hypertension and the Role of Combination Therapy. The Journal of Clinical Hypertension, 10(s1), pp.4-12.

    View at Publisher | View at Google Scholar
  • Schunkert H, Glazer RD, Wernsing M, Yen J, Macarie CE, et al. 2009. Efficacy and tolerability of amlodipine/valsartan combination therapy in hypertensive patients not adequately controlled on amlodipine monotherapy. Current medical research and opinion, 25(11), pp.2655-2662.

    View at Publisher | View at Google Scholar
  • Kjeldsen SE, Weber M, Oparil S and Jamerson KA, 2008. Combining RAAS and calcium channel blockade: ACCOMPLISH in perspective. Blood pressure, 17(5-6), pp.260-269. View at Publisher | View at Google Scholar | View at Indexing
  • Jamerson KA and Basile J, 2008. Prompt, Aggressive BP Lowering in High‐Risk Patients. The Journal of Clinical Hypertension, 10(s1), pp.40-48. View at Publisher | View at Google Scholar | View at Indexing
  • Huang J, Sun NL, Hao YM, Zhu JR, Tu Y, et al. 2011. Efficacy and tolerability of a single-pill combination of amlodipine/valsartan in Asian hypertensive patients not adequately controlled with valsartan monotherapy. Clinical and Experimental Hypertension, 33(3), pp.179-186. View at Publisher | View at Google Scholar | View at Indexing
  • Effects of Valsartan / Amlodipine Compound Tablets on Patients with Mild and Moderate Hypertension with Poor Drugs. Chinese Journal of Cardiovascular Diseases, 37 (9), pp. 794-799.

    View at Publisher | View at Google Scholar
  • Fogari R, Mugellini A, Preti P, Zoppi A and Derosa G, 2010. Valsartan addition to amlodipine is more effective than losartan addition in hypertensive patients inadequately controlled by amlodipine. Vascular health and risk management, 6, p.87. View at Publisher | View at Google Scholar | View at Indexing
  • Destro M, Crikelair N, Yen J and Glazer R, 2010. Triple combination therapy with amlodipine, valsartan, and hydrochlorothiazide vs dual combination therapy with amlodipine and hydrochlorothiazide for stage 2 hypertensive patients. Vascular health and risk management, 6, pp.821-827. View at Publisher | View at Google Scholar | View at Indexing
  • Smith TR, Glazer RD, Koren MJ, Wernsing M and Zhang Y, 2010. Combination therapy with amlodipine/valsartan in essential hypertension: a 52‐week, randomised, open‐label, extension study. International journal of clinical practice, 64(10), pp.1367-1374. View at Publisher | View at Google Scholar | View at Indexing
  • Destro M, Cagnoni F, D’Ospina A, Ricci AR, Demichele E, et al. 2010. Role of valsartan, amlodipine and hydrochlorothiazide fixed combination in blood pressure control: an update. Vascular health and risk management, 6, p.253. View at Publisher | View at Google Scholar | View at Indexing
  • Philipp T, Glazer RD, Zhao Y and Pospiech R, 2009. Long-term tolerability and efficacy of the combination of amlodipine/valsartan in hypertensive patients: a 54-week, open-label extension study. Current medical research and opinion, 25(1), pp.187-193. View at Publisher | View at Google Scholar | View at Indexing
  • Rathnakar UP, Shenoy A, Ullal SD, Sudhakar P, Shastry R, et al. 2011. Prescribing patterns of fixed dose combinations in hypertension, diabetes mellitus and dyslipedimia among patients attending a cardiology clinic in a tertiary care teaching hospital in india. International Journal of Comprehensive Pharmacy, 2(6), pp.1-3. View at Publisher | View at Google Scholar | View at Indexing
  • Destro M, Cagnoni F, D'Ospina A, Ricci AR, Zaninelli A, et al. 2010. New strategies and drugs in the treatment of hypertension: monotherapy or combination?. Recent patents on cardiovascular drug discovery, 5(1), pp.69-81. View at Publisher | View at Google Scholar | View at Indexing
  • Duan J, Chen J, Yin Q, Karan R, Meiser K, et al. 2012. Pharmacokinetics of single and multiple oral doses of valsartan/amlodipine (80/5 mg) in healthy Chinese subjects. International journal of clinical pharmacology and therapeutics, 50(1), pp.33-43. View at Publisher | View at Google Scholar | View at Indexing
  • Effects of levamlodipine besylate and valsartan on hypertension in the treatment of hypertension. Chinese Journal of Integrative Medicine on Cardio / Cerebrovascular Diseases, 11 (5), pp.542-543.

    View at Publisher | View at Google Scholar
  • Fogari R and Zoppi A, 2010. Clinical benefits from combination therapy in the treatment of hypertension. Hipertensión y riesgo vascular, 27(3), pp.108-116.

    View at Publisher | View at Google Scholar
  • Hu Hailong, 2010. Clinical observation of enalapril combined with levamlodipine besylate in the treatment of essential hypertension. Chinese and foreign medical treatment, 29 (17), pp.101-102. View at Publisher | View at Google Scholar | View at Indexing
  • Gorostidi M and De la Sierra A, 2010. Antagonistas de los receptores de la angiotensina II en combinación con antagonistas del calcio. Focus en la asociación de olmesartán con amlodipino. Hipertensión y Riesgo Vascular, 27, pp.16-21.

    View at Publisher | View at Google Scholar
  • Gorostidi M and De la Sierra A, 2010. Antagonistas de los receptores de la angiotensina II en combinación con antagonistas del calcio. Focus en la asociación de olmesartán con amlodipino. Hipertensión y Riesgo Vascular, 27, pp.16-21.

    View at Publisher | View at Google Scholar

Relevant Topics

Select your language of interest to view the total content in your interested language

Journal Metrics:

Impact Factor: 5.45
Journal Citescore: 6.20
h-index: 29
PubMed NLM ID:  101579384
Journal Acceptance Rate: 40%
Article processing time : 30-45 Days

Google Scholar citation report
Citations : 3847

Clinical Practice received 3847 citations as per Google Scholar report


Clinical Practice peer review process verified at publons

Indexed In

flyer
flyer